NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Standard Model Biomedicine

Standard Model Biomedicine

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://standardmodel.bio/

Last Round

Seed

Oct 6, 2025

Company Overview

Standard Model Biomedicine is a biotechnology company that develops multimodal AI foundation models to integrate biomedical data for patient outcome prediction and clinical research.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

foundation modelfrontier ai labcomputational biologydrug discoverybiotech aitarget identificationelectronic health recordEHRpatient embeddingsmultimodal aiproteomicsgenomicsbioinformaticsai drug discoverybiotech saas

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Standard Model Biomedicine Comps

Public and private peers based on sector, stage, and business model.

Standard Model Biomedicine comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Standard Model Biomedicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 6, 2025

Key People

Founding team and executive leadership

Arda Pekis

Founder, CTO

Founding Team

Kevin Brown

Founder CEO

Founding Team

Standard Model Biomedicine Investors

Notable investors and investment history

Standard Model Biomedicine investors
InvestorRounds
Arkitekt VenturesSeed
VirtueSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2025

    Grew 75% QoQ, from 4 to 7 employees.

  • Nov 14, 2024

    Grew 400% QoQ from 1 to 5 employees.

Standard Model Biomedicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Standard Model Biomedicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Standard Model Biomedicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range11
Year Founded2024
Last FundingOct 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.